Sanctum Therapeutics’ Merger With Adnexus Biotechnologies

Norton Rose Fulbright represented Sanctum Therapeutics Corporation in the transaction.Adnexus Biotechnologies Inc. (Adnexus) executed a merger agreement with Sanctum Therapeutics Corporation to acquire Sanctum Therapeutics and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here